- Likely to be one of the first of the 10 breakthroughs to come to fruition, single-cell analysis will allow scientists to study individual cells in their normal environment for the first time. The ability to determine which genes are turned on or off in individual cells, and to decode how immune cells attack healthy tissue, will transform how we approach autoimmune diseases and how we combat the deadly process of cancer metastasis.
Denna professor,Francis Collins - Director of the National Institutes of Health (NIH), som alltså är verksam på det statliga amerikanska hälsodepartementet.
- Francis S. Collins, M.D., Ph.D. was appointed the 16th Director
of the National Institutes of Health (NIH) by President Barack Obama
and confirmed by the Senate. He was sworn in on August 17, 2009. On June
6, 2017, President Donald Trump announced his selection of Dr. Collins
to continue to serve as the NIH Director. In this role, Dr. Collins
oversees the work of the largest supporter of biomedical research in the
world, spanning the spectrum from basic to clinical research.
Dr. Collins is a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the international Human Genome Project, which culminated in April 2003 with the completion of a finished sequence of the human DNA instruction book. He served as director of the National Human Genome Research Institute at NIH from 1993-2008.
Before coming to NIH, Dr. Collins was a Howard Hughes Medical Institute investigator at the University of Michigan. He is an elected member of the National Academy of Medicine and the National Academy of Sciences, was awarded the Presidential Medal of Freedom in November 2007, and received the National Medal of Science in 2009.
Dr. Collins is a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the international Human Genome Project, which culminated in April 2003 with the completion of a finished sequence of the human DNA instruction book. He served as director of the National Human Genome Research Institute at NIH from 1993-2008.
Before coming to NIH, Dr. Collins was a Howard Hughes Medical Institute investigator at the University of Michigan. He is an elected member of the National Academy of Medicine and the National Academy of Sciences, was awarded the Presidential Medal of Freedom in November 2007, and received the National Medal of Science in 2009.
NIH som så överraskande för 5 månader sen (11 Sep) införskaffade sig sin första HoloMonitor. Ni minns att institutet skippade upphandlingsprocedurerna och med det visade att man hade bestämt sig för PHI`s eminenta HoloMonitor redan från scratch. Månaden efter (29 Okt) berättade sen Francis i den uppmärksammade intervjun att tekniken PHI besitter (Single cell analysis) värderar han som den viktigaste för detta decennium.
Ett utdrag ur intervjun :
10 ways medical innovation will transform our lives over the next decade.
Emerging technologies look set to transform the healthcare industry. In this year's Global Innovation Index, Francis Collins, Director of the National Institutes of Health (NIH), explores some of the innovations that could have the biggest impact in the next decade. Here's a summary of those findings from the report.
Every day, medical innovations lengthen and improve lives across the globe. Over the course of the next decade, as twenty-first century technologies combine and accelerate, healthcare is set for a revolution.
These trends are leading to breakthroughs across a range of medical frontiers. For this year’s GII, the NIH identified 10 of the cutting-edge emerging technologies most likely to revolutionize healthcare over the next decade.
Here’s a closer look at the technologies that made the list:
1. Single cell analysis
Likely to be one of the first of the 10 breakthroughs to come to fruition, single-cell analysis will allow scientists to study individual cells in their normal environment for the first time. The ability to determine which genes are turned on or off in individual cells, and to decode how immune cells attack healthy tissue, will transform how we approach autoimmune diseases and how we combat the deadly process of cancer metastasis.
Detta är alltså inga nyheter så ni är medvetna om det.
Nyhet däremot är som rubriken för detta inlägg berättar, anrika Oxford via forskaren Volodymyr Nechyporuk-Zloy, delar Francis Collins vision. Det genom att på sin Linkedinsida ge uppmärksamhet åt intervjun samt även lägga till vilket instrument han kopplar till visionen.
Låt oss hoppas att denna vision snabbt når världens cancerforskare så dessa tar till sig tekniken och jämnar ut oddsen att besegra denna best.
Inga kommentarer:
Skicka en kommentar